SignatureFD’s Nuvation Bio NUVB Stock Holding History

SignatureFD’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.71K	Hold	654	–	–	﹤0.01%	2964
2026 Q1	$2.81K	Hold	654	–	–	﹤0.01%	2967
2025 Q4	$5.86K	Sell	654 -429	-40%	-$2.66K	﹤0.01%	2634
2025 Q3	$4.01K	Hold	1,083	–	–	﹤0.01%	2747
2025 Q2	$2.11K	Sell	1,083 -43	-4%	-$90	﹤0.01%	2852
2025 Q1	$1.98K	Hold	1,126	–	–	﹤0.01%	2878
2024 Q4	$3K	Sell	1,126 -537	-32%	-$1.38K	﹤0.01%	2760
2024 Q3	$3.81K	Buy	1,663 +537	+48%	+$1.64K	﹤0.01%	2648
2024 Q2	$3.29K	Hold	1,126	–	–	﹤0.01%	2630
2024 Q1	$4.1K	Hold	1,126	–	–	﹤0.01%	2604
2023 Q4	$1.7K	Buy	+1,126	New	+$1.45K	﹤0.01%	2803
2023 Q2	–	Sell	-922	Closed	-$1.53K	–	3324
2023 Q1	$1.53K	Sell	922 -6,330	-87%	-$12.8K	﹤0.01%	2879
2022 Q4	$13.9K	Buy	7,252 +4,172	+135%	+$8.44K	﹤0.01%	1980
2022 Q3	$7K	Buy	+3,080	New	+$8.79K	﹤0.01%	2258

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SignatureFD's NUVB Position: Q2 2026 in Review

SignatureFD held its Nuvation Bio (NUVB) position steady in Q2 2026 at 654 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2964.

SignatureFD first reported a position in NUVB in Q3 2022 and has held it in 14 quarters since. The position peaked at $13.9K in Q4 2022. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

SignatureFD held 654 shares of Nuvation Bio worth $3.71K as of Q2 2026.
SignatureFD left its Nuvation Bio share count unchanged in Q2 2026.
Nuvation Bio made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2964 holding.
SignatureFD first reported a position in Nuvation Bio in Q3 2022 and has held it in 14 quarters since.
SignatureFD's Nuvation Bio position peaked at $13.9K in Q4 2022.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.